NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/08/2025
Voltar para busca
Dado oficial do USPTO
INVICRO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
26/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 41, 42, 44
Data de depósito
08/09/2021
Data de registro
26/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/08/2025
Última transação
26/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2008-08-00
Primeiro uso no comércio
2008-08-00
Código do desenho
3
Tipo de titular
16
Localização do titular
Needham, MA, US
Examinador
JOHNSON, DANYTHE ELIZABETH HA
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of an image of an overhead shot of a magnifying glass with a loupe in the circle with the word "INVICRO" to the right of the image.
Titulares e representantes
Titulares
Invicro, LLC
Representantes
Devon E. White Wyrick Robbins Yates & Ponton LLP
Classificação técnica
Classes Nice
Classe 9Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for processingvisualizingstoring and analyzing pre-clinical and clinical radiology and pathology image data in the fields of drug development and disease research; downloadable computer software for image data management purposespre-clinical and clinical image database management and research subject records management; downloadable computer software for processing multi-modal imaging data; downloadable computer software for the processingstorage and analysis of multi-modal imaging data for quantitation and evaluation of biomarkers and drug candidates; downloadable software for the assessment of tumors for research through use of biomarkers
Classe 41
Educational servicesdevelopingarranging and conducting educational programspanel discussions and non-downloadable webinars in the fields of pharmaceuticalsbiotechnologypre-clinical and clinical trialsmedical research; educational servicesproviding non-downloadable publications in the nature of blogposts and magazinesnon-downloadable literature in the nature of periodicals and books in the fields of pharmaceuticalsbiotechnologypre-clinical and clinical trialsmedical research
Classe 42
Medical and scientific researchconducting clinical trial services for others and pre-clinical trial services for others in the nature of testing of pharmaceuticals; pharmaceutical research and development services; testing of pharmaceutical pharmacodynamicspharmacokinetics and efficacy using a variety of imaging modalities and imaging analysis platforms; imaging services and pathology in support of pharmaceutical research and developmentresearch of disease and non-medical ultrasound imaging servicesall for the research and development of pharmaceuticals; drug discovery services; conducting early evaluations in the field of new drugs; scientific investigations for medical research purposes; medical and scientific research laboratory services; medical and scientific researchproviding analysis of imaging data obtained from pre-clinical and clinical trial studies; medical and scientific research in the fields of medical radiology imagingpathology and digital pathology; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; research and development in the fields of medical imagingpharmaceuticals and biotechnology; designdevelopmentmaintenance and updating of computer software for image processingstorage and analysis in the fields of pharmaceuticals and biotechnology; electronic storage of medical images; processing of medical imagesdigital image interpretation for scientific research and medical research purposeslabelingcorrectionrestoration and enhancement; pathology services in support of drug developmentmedical research regarding diseases for the purpose of developing drugs; hosting of a medical imaging analysis and visualization platform in the nature of a website through a global computer network; hosting of digital content on the Internethosting of a database of medical images; software as a service (SAAS) featuring computer software platforms for image processingstorage and analysis in the fields of pharmaceuticals and biotechnology; conducting clinical trials for others at all stages and in various indicationsparticularly in oncologyneurology and systemic diseases; imaging contract research organization services and technology solutionsnon-medical ultrasound imaging services for medical and scientific research purposes and technology solutionsreviewing of radiology images throughout the clinical trial process and blinded independent central review of radiology images in the medical research and clinical trial setting for medical research and scientific research purposes; scientific research servicesintegration of imaging results with clinical outcome datawith application of machine learning and artificial intelligence applications; development and evaluation in the nature of testing of imaging biomarkers for clinical trial purposes; software consulting services in the field of drug discovery; cloud computing featuring software for use in database management for use in pharmaceutical drug research in the field of drug discovery; radiochemistry services in the nature of radiolabeling for scientific research and medical research purposes and radiochemical analysis; researchdevelopment and testing services relating to radiopharmaceuticals; radiolabeling scientific researchlabeling of both small molecules and biologics; providing non-downloadable web-based computer software for database management in the fields of medical imagingpharmaceutical and biotechnology research; medical imaging and radiology services related to drug developmentmedical imaging and radiology services of clinical trial patients for research purposes; medical and scientific research services in the fields of magnetic resonance and molecular imaging; medical research servicesin particular services relating to the development of radiotherapeutics and drug candidates for neurodegenerative diseases and precision oncology; image analysis and radiologyanalysis of images from all radiological modalitiessuch as but not limited to CTMRI and PET scansto provide quantitative evaluation of drug candidates medical radiologymolecular imagingimaging utilizing radiopharmaceuticals for medical research and pharmaceutical development purposes; pathology servicestesting for research purposes in the fields of pharmaceuticals and biotechnology; pathology services for preclinical biomarker discovery research and clinical trials
Classe 44
Medical imaging services; medical imaging and radiology services related to drug developmentmedical imaging and radiology services of clinical trial patients for medical purposes; image analysis and radiologyanalysis of images from all radiological modalitiessuch as but not limited to CTMRI and PET scans to provide quantitative evaluation of drug candidates medical radiologymolecular imagingimaging utilizing radiopharmaceuticals for the diagnosis and medical treatment of trial candidates; radiomicsmedical radiology services; medical imaging servicesmedical imaging and extraction of imaging biomarkers; analysis of medical imagesmedical analysis of medical images for diagnosis and treatment of persons in clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
20/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/04/2025
GNRT
NON-FINAL ACTION E-MAILED
03/04/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/03/2025
EX3G
SOU EXTENSION 3 GRANTED
02/03/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/03/2025
IUAF
USE AMENDMENT FILED
19/12/2024
EXT3
SOU EXTENSION 3 FILED
19/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
19/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
19/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/06/2024
EX2G
SOU EXTENSION 2 GRANTED
20/06/2024
EXT2
SOU EXTENSION 2 FILED
20/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
20/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/06/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
22/05/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
22/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/12/2023
EX1G
SOU EXTENSION 1 GRANTED
13/12/2023
EXT1
SOU EXTENSION 1 FILED
13/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
13/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/04/2023
PUBO
PUBLISHED FOR OPPOSITION
25/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
17/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
17/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2023
ALIE
ASSIGNED TO LIE
11/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/12/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/06/2022
GNRT
NON-FINAL ACTION E-MAILED
29/06/2022
CNRT
NON-FINAL ACTION WRITTEN
29/06/2022
DOCK
ASSIGNED TO EXAMINER
13/06/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
19/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/10/2021
NWAP
NEW APPLICATION ENTERED
11/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INVICRO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.